BioLoomics
Latest round
- Seed
Last raised
- Sep 2023
Total raised
- $8.7M
Investors
- 7
About BioLoomics
, operates as a biotechnology company focused on the evolution of antibodies in human cells. The company offers drug discovery tools and protein drugs used to accelerate the rate of discovery of promising drug activity, enabling the development of safer and more efficient cancer treatments. The company uses synthetic biology, artificial intelligence (AI), imaging, and robotics technology to conduct activity-guided antibody library screening.
Who invested in BioLoomics
7 investors across 1 round
See all investors in BioLoomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 19, 2023
Amount
$8.7M
Investors
Questions about BioLoomics
Who invested in BioLoomics?
BioLoomics has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioLoomics raised?
BioLoomics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BioLoomics last raise money?
BioLoomics's most recent round on record is a Seed, in Sep 2023.
What does BioLoomics do?
, operates as a biotechnology company focused on the evolution of antibodies in human cells.
Where is BioLoomics headquartered?
BioLoomics is headquartered in Boulder, US.
Which VCs invest in companies like BioLoomics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at BioLoomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like BioLoomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.